Medicamen Organics Limited (NSE:MEDIORG)

India flag India · Delayed Price · Currency is INR
21.80
-1.10 (-4.80%)
Mar 6, 2026, 3:25 PM IST
Market Cap255.06M -57.1%
Revenue (ttm)394.30M +28.0%
Net Income45.74M +79.2%
EPS3.84 +39.1%
Shares Out11.70M
PE Ratio5.68
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,000
Average Volume17,700
Open22.00
Previous Close22.90
Day's Range21.80 - 22.05
52-Week Range19.60 - 49.70
Betan/a
RSI38.12
Earnings DateFeb 13, 2026

About Medicamen Organics

Medicamen Organics Limited develops, manufactures, and distributes a range of pharmaceutical dosage. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It also provides skincare, haircare, and cosmetic products unde... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1995
Employees 114
Stock Exchange National Stock Exchange of India
Ticker Symbol MEDIORG
Full Company Profile

Financial Performance

In fiscal year 2025, Medicamen Organics's revenue was 381.88 million, an increase of 51.11% compared to the previous year's 252.72 million. Earnings were 40.47 million, an increase of 54.22%.

Financial Statements